Montoya Christopher, Polania-Sandoval Camilo, Almeida Jose I
Division of Vascular and Endovascular Surgery, DeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, FL.
J Vasc Surg Cases Innov Tech. 2024 Feb 14;10(3):101432. doi: 10.1016/j.jvscit.2024.101432. eCollection 2024 Jun.
Venous in-stent restenosis is not completely understood, and the currently available treatment is usually unsatisfactory. We describe the cases of two patients treated with the RevCore thrombectomy system (Inari Medical), designed for venous in-stent thrombosis. Case 1 involves a 62-year-old woman with post-thrombotic syndrome from iliac vein stent placement 15 years earlier. Case 2 describes a 30-year-old woman with post-thrombotic syndrome from recurrent iliac vein stent occlusion, despite therapeutic anticoagulation. Both patients had previous recanalization attempts at outside facilities that were unsuccessful. The RevCore system was safe and feasible in these initial cases, and more studies are warranted.
静脉支架内再狭窄的机制尚未完全明确,目前可用的治疗方法通常效果不佳。我们描述了两名使用RevCore血栓切除术系统(Inari Medical公司)治疗的患者,该系统专为静脉支架内血栓形成设计。病例1为一名62岁女性,15年前因髂静脉支架置入术后出现血栓后综合征。病例2为一名30岁女性,尽管接受了抗凝治疗,但因髂静脉支架反复闭塞而出现血栓后综合征。两名患者此前在外院进行的再通尝试均未成功。在这些初始病例中,RevCore系统安全可行,有必要开展更多研究。